Giuseppe Curigliano: Celebrating Gender Equity and Inclusion with Dr. Don S. Dizon at ASCO24

Giuseppe Curigliano shared on LinkedIn:

“Celebrating Gender Equity and Inclusion with the inspiring Dr. Don S. Dizon at ASCO24! Together, we’re making strides towards a more inclusive and equitable future in oncology. Proud to stand with the Editor-in-Chief of CA: A Cancer Journal for Clinicians.”

Source: Giuseppe Curigliano/LinkedIn

Giuseppe Curigliano is the Director of  the Early Drug Development Division and co-chairs the Experimental Therapeutics Program at the European Institute of Oncology. He is a member of the Department of Oncology and Hemato-Oncology’s steering committee at the University of Milan and serves on the Italian National Health Council, advising the Ministry of Health on cancer policy issues.